MIRA
INFORM REPORT
|
Report Date : |
14.02.2013 |
IDENTIFICATION DETAILS
|
Name : |
PRADIPKUMAR PHARMA PRIVATE LIMITED |
|
|
|
|
Formerly Known As : |
PRADIPKUMAR AND COMPANY (PHARMA) PRIVATE LIMITED |
|
|
|
|
Registered Office : |
701, 7th Floor, Arun
Chambers, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2012 |
|
|
|
|
Date of Incorporation : |
26.08.1991 |
|
|
|
|
Com. Reg. No.: |
11-063069 |
|
|
|
|
Capital Investment / Paid-up Capital : |
Rs.30.000 Millions |
|
|
|
|
CIN No.: [Company
Identification No.] |
U99999MH1991PTC063069 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
MUMP10049E |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
Import, Export and Trading in
Bulk drugs. |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B (46) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 249468 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established
company having Satisfactory track. The company is progressing well. The company
has declared interim dividend of Rs.5 per share. Trade relations are reported
as fair. Business is active. Payments are reported to be usually correct and
as per commitments. The company can be considered for normal for business dealings at usual trade terms and conditions. |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
India is developing into an open-market economy, yet traces
of its past autarkic policies remain. Economic liberalization, including industrial
deregulation, privatization of state-owned enterprises, and reduced controls on
foreign trade and investment, began in the early 1990s and has served to
accelerate the country's growth, which has averaged more than 7% per year since
1997. India's diverse economy encompasses traditional village farming, modern
agriculture, handicrafts, a wide range of modern industries, and a multitude of
services. Slightly more than half of the work force is in agriculture, but
services are the major source of economic growth, accounting for more than half
of India's output, with only one-third of its labor force. India has
capitalized on its large educated English-speaking population to become a major
exporter of information technology services and software workers. In 2010, the
Indian economy rebounded robustly from the global financial crisis - in large
part because of strong domestic demand - and growth exceeded 8% year-on-year in
real terms. However, India's economic growth in 2011 slowed because of persistently
high inflation and interest rates and little progress on economic reforms. High
international crude prices have exacerbated the government's fuel subsidy
expenditures contributing to a higher fiscal deficit, and a worsening current
account deficit. Little economic reform took place in 2011 largely due to
corruption scandals that have slowed legislative work. India's medium-term
growth outlook is positive due to a young population and corresponding low
dependency ratio, healthy savings and investment rates, and increasing
integration into the global economy. India has many long-term challenges that
it has not yet fully addressed, including widespread poverty, inadequate
physical and social infrastructure, limited non-agricultural employment
opportunities, scarce access to quality basic and higher education, and
accommodating rural-to-urban migration.
|
Source
: CIA |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CRISIL |
|
Rating |
SE1B |
|
Rating Explanation |
Highest Performance capability and moderate financial Strength |
|
Date |
31.07.2012 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
LOCATIONS
|
Registered Office : |
701, 7th Floor, Arun Chambers,
|
|
Tel. No.: |
91-22-22082069/ 22081770/
22085118/ 22085119/ 22332345/ 40312222/ (Resi) 3872936 / 40312222 |
|
Fax No.: |
91-22-22085113/ 22082069/
40312200 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory : |
Gala No. 5/6, Manish Compound, Rehnal Village, Anjur Phata, Thane Road, Bhiwandi – 421308, Maharashtra, India |
DIRECTORS
AS ON 29.09.2012
|
Name : |
Mr. Pradipkumar Ramanlal Shah |
|
Designation : |
Managing Director |
|
Address : |
1301, Veena Apartment, 198, |
|
Date of Birth/Age : |
05.04.1947 |
|
Qualification : |
B. Com |
|
Date of Appointment : |
26.08.1991 |
|
DIN No.: |
01147637 |
OTHER DIRECTORSHIP:
|
S.No. |
CIN/LLPIN |
Name of the
Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date of
appointment at current designation |
Original date of
appointment |
Date of
cessation |
Company/ LLP
Status |
Defaulting
status |
|
1 |
U99999MH1991PTC063069
|
PRADIPKUMAR
PHARMA PRIVATE LIMITED |
Managing
director |
26/08/1991 |
26/08/1991 |
- |
Active |
NO |
|
Name : |
Mr. Dinesh Ramanlal Shah |
|
Designation : |
Whole-Time Director |
|
Address : |
8, Songadh Apartments, 4th
Floor, 48, |
|
Date of Birth/Age : |
22.05.1959 |
|
Qualification : |
B. A. |
|
Date of Appointment : |
01.04.1995 |
|
DIN NO. |
01147934 |
OTHER DIRECTORSHIP:
|
S.No. |
CIN/LLPIN |
Name of the
Company/ LLP |
Current designation
of the Director/ Designated Partner |
Date of
appointment at current designation |
Original date of
appointment |
Date of
cessation |
Company/ LLP
Status |
Defaulting
status |
|
1 |
U99999MH1991PTC063069
|
PRADIPKUMAR PHARMA
PRIVATE LIMITED |
Whole-time
director |
01/04/1995 |
01/04/1995 |
- |
Active |
NO |
|
Name : |
Mr. Umesh Ramanlal Shah |
|
Designation : |
Whole Time Director |
|
Address : |
22 Suraj Apartments, 274, |
|
Date of Birth/Age : |
25.06.1957 |
|
Qualification : |
B. Com |
|
Date of Appointment : |
01.04.1995 |
|
DIN No.: |
01147872 |
OTHER DIRECTORSHIP:
|
S.No. |
CIN/LLPIN |
Name of the
Company/ LLP |
Current designation
of the Director/ Designated Partner |
Date of
appointment at current designation |
Original date of
appointment |
Date of
cessation |
Company/ LLP
Status |
Defaulting
status |
|
1 |
U99999MH1991PTC063069
|
PRADIPKUMAR PHARMA
PRIVATE LIMITED |
Whole-time
director |
01/04/1995 |
01/04/1995 |
- |
Active |
NO |
|
Name : |
Mr. Dhiren Ramanlal Shah |
|
Designation : |
Director |
|
Address : |
1, Ravindra Kutir, 29-B, |
|
Date of Birth/Age : |
27.10.1955 |
|
Date of Appointment : |
01.04.1995 |
|
DIN No.: |
01222891 |
OTHER DIRECTORSHIP:
|
S.No. |
CIN/LLPIN |
Name of the
Company/ LLP |
Current
designation of the Director/ Designated Partner |
Date of appointment
at current designation |
Original date of
appointment |
Date of
cessation |
Company/ LLP
Status |
Defaulting
status |
|
1 |
U99999MH1991PTC063069
|
PRADIPKUMAR
PHARMA PRIVATE LIMITED |
Director |
01/04/1995 |
01/04/1995 |
- |
Active |
NO |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 29.09.2012
|
Names of Shareholders |
|
No. of Shares |
|
R. Pradipkumar Ramanlal |
|
31680 |
|
Pradipkumar R. Shah (HUF) |
|
29700 |
|
R. Pradipkumar Ramanlal Joint with P. Pravina Pradipkumar |
|
39660 |
|
P. Pravina Pradipkumar Joint with R. Pradipkumar Ramanlal |
|
27300 |
|
Ramanlal Shah (HUF) |
|
28710 |
|
Nipa D. Shah Joint with Dinesh
R. Shah |
|
37200 |
|
Pradipkumar Pravina P Shah joint
with Ramanlal Pradeepkumar R Shah |
|
40650 |
|
Dinesh R. Shah (HUF) |
|
19800 |
|
Dhirenh R. Shah (HUF) |
|
19800 |
|
Alok Shah Joint with Dhiren Shah
|
|
19800 |
|
Ramanlal Dhiren Shah Joint with Dhiren R. Shah |
|
30750 |
|
Dhiren R. Shah Joint with Ramanlal Dhiren Shah |
|
27300 |
|
Ramanlal Umesh R Shah Joint with
Priti Umesh Shah |
|
30750 |
|
Umesh Priti Shah Joint with
Ramanlal Umesh Shah |
|
27300 |
|
Umesh Shah Joint with Ramanlal
Umesh Shah |
|
19800 |
|
Umesh R. Shah (HUF) |
|
19800 |
|
Total |
|
450000 |
AS ON 29.09.2012
Equity Share Break up (Percentage of Total Equity)
|
Category |
Percentage |
|
Directors or relatives of Directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Import, Export and Trading in Bulk
drugs. |
||||||||||||||
|
|
|
||||||||||||||
|
Products : |
·
Phenelephrine ·
Sulphamethoxazole ·
Metronidazole ·
Ofloxacin USP 24 · Tetracpy Cycline HCL · Norfloxacin USP 24 ·
Aerosil 200, Degusa ·
Albendazole CP, ·
·
·
Analgin Dab10, ·
Aspartham USP24, ·
Aspartam USP24, ·
·
Atropine Methyl Nitrate, German · Atropine Sulphate IP/BP/USP, German ·
Atropine Sulphate IP/BP/USP, German ·
Tropine Sulphate IP/BP/USP, German ·
Atropine Sulphate IP/BP/USP, ·
Atropine Sulphate IP/BP/USP, ·
·
·
C. P. Maleate I.P., ·
Calcium D. Pantothenate BP, ·
Ntothenate BP, ·
Calcium Pantothenate Feed 45%, ·
Calcium Lactate BP98, ·
·
Chlomipramine HCL, ·
Chloramphenicol I. P., |
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Bankers : |
·
Bank of India,
Bullion Exchange Branch, 185 Sheikh Memon Street, Kalbadevi Road, Mumbai –
400002, Maharashtra, India ·
HDFC Bank Limited |
||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
B. B. Lakdawala and Company Chartered Accountants |
|
Address : |
|
|
Tel. No.: |
91-22-26201767 |
|
Telfax No.: |
91-22-26236706 |
|
PAN No.: |
AAAPL7669Q |
|
|
|
|
Associates/Subsidiaries : |
NA |
CAPITAL STRUCTURE
AS ON 31.03.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
450000 |
Equity Shares |
Rs.100/- each |
Rs.45.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
450000 |
Equity Shares (150000 Equity Shares of Rs.100/- each fully paid Bonus shares are issued in the ratio at 1:2 out of free Reserves) |
Rs.100/- each |
Rs.45.000 Millions |
|
|
|
|
|
|
Particulars of Equity Share Holding more the 5% |
31.03.2012 |
|
Pradipkumar R. Shah |
40650 (9.03%) |
|
Pravina P. Shah |
27300 (6.07%) |
|
Pradipkumar R. Shah – HUF |
29700 (
6.60 %) |
|
Dhiren R. Shah |
30750 ( 6.83 % )
|
|
Tejal Dhiren Shah |
27300 ( 6.07 % )
|
|
Umesh R. Shah |
30750 ( 6.83 % )
|
|
Priti Umesh Shah |
27300 ( 6.07 % )
|
|
Dinesh R. Shah |
40650 ( 9.03 % )
|
|
Nipa Dinesh Shah |
37200 ( 8.27 % )
|
|
Executors of Subhadra R. Shah |
29700 ( 6.60 % )
|
|
Ramanlal P. Shah - HUF |
28710
(6.38%) |
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
45.000 |
30.000 |
30.000 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
17.367 |
17.744 |
8.638 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
62.367 |
47.744 |
38.638 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
49.929 |
19.883 |
7.285 |
|
|
2] Unsecured Loans |
113.255 |
86.220 |
81.247 |
|
|
TOTAL BORROWING |
163.184 |
106.103 |
88.532 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
225.551 |
153.847 |
127.170 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
6.928 |
4.032 |
4.255 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.192 |
0.215 |
0.204 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
59.259 |
45.113 |
49.733 |
|
|
Sundry Debtors |
285.491 |
161.681 |
114.502 |
|
|
Cash & Bank Balances |
4.923 |
4.722 |
5.764 |
|
|
Other Current Assets |
8.468 |
9.600 |
7.897 |
|
|
Loans & Advances |
2.421 |
4.806 |
0.582 |
|
Total
Current Assets |
360.562 |
225.922 |
178.478 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
123.721 |
61.655 |
45.590 |
|
|
Other Current Liabilities |
18.410 |
14.667 |
10.128 |
|
|
Provisions |
0.000 |
0.000 |
0.049 |
|
Total
Current Liabilities |
142.131 |
76.322 |
55.767 |
|
|
Net Current Assets |
218.431 |
149.600 |
122.711
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
225.551 |
153.847 |
127.170 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
|
516.496 |
459.906 |
|
|
|
Other Income |
|
13.113 |
14.091 |
|
|
|
TOTAL (A) |
632.507 |
529.609 |
473.997 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Office Expenses |
|
|
|
|
|
|
Administrative Expenses |
|
|
|
|
|
|
Advertising Expenses |
|
|
|
|
|
|
TOTAL (B) |
NA |
501.294 |
453.897 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
35.978 |
28.315 |
20.100 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
12.784 |
11.478 |
10.482 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
23.194 |
16.837 |
9.618 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
1.011 |
1.132 |
0.903 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
22.183 |
15.705 |
8.715 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
5.816 |
5.550 |
2.724 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
16.367 |
10.155 |
5.991 |
|
|
|
|
|
|
|
|
|
|
PREVIOUS YEARS’
BALANCE BROUGHT FORWARD |
17.744 |
8.338 |
19.102 |
|
|
|
|
|
|
|
|
|
|
APPROPRIATIONS |
|
|
|
|
|
|
|
Bonus Shares |
15.000 |
0.000 |
5.000 |
|
|
|
Dividend |
1.500 |
0.000 |
1.500 |
|
|
|
Tax on Dividend |
0.243 |
0.000 |
0.255 |
|
|
BALANCE CARRIED
TO THE B/S |
17.368 |
18.493 |
8.338 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
36.37 |
33.96 |
19.97 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
PAT / Total Income |
(%) |
2.59 |
1.92 |
1.26
|
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
NA
|
3.04
|
1.89 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
6.03 |
6.83 |
4.77
|
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.36 |
0.33 |
0.23
|
|
|
|
|
|
|
|
Debt Equity Ratio (Debt/Networth) |
|
2.62 |
2.22 |
2.29
|
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.54 |
2.96 |
3.20
|
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
Yes |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact
person |
No |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
-------- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
No |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
---------------------- |
|
22] |
Litigations that the firm
/ promoter involved in |
---------------------- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
---------------------- |
|
26] |
Buyer visit details |
No |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
No |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
No |
|
34] |
External Agency Rating,
if available |
Yes |
OPERATING AND
FINANCIAL RESULTS:
The Company’s Sales during the year amounted to Rs. 613.976 Millions
compared to Rs.516.496 Millions in the previous year thus registering an increase
by 18.88% and other income amounted to Rs.18.530 Millions. The same enabled the
Company to reflect net profit of Rs.16.366 Millions after making provision for
tax amounting to Rs.5.793 Millions compared to Net Profit of Rs.10.155 Millions
in the previous year.
NOTE:
The Registered Office of the
company has been shifted from Shreeji Bhuwan, 2nd Floor, Mangaldas
Road, Lohar Chawl, Mumbai – 400002, Maharashtra, India, to the present address
w.e.f. 18.12.2008.
BANKERS CHARGES
REPORT AS PER REGISTRY
|
Corporate
identity number (CIN) Foreign company registration number |
U99999MH1991PTC063069 |
|
Name of the
Company |
PRADIPKUMAR PHARMA PRIVATE LIMITED |
|
Address |
701, 7th Floor, Arun
Chambers, |
|
This form is for |
Modification of Charge |
|
Charge
identification (ID) number of the charge to be modified |
90163097 |
|
Type of Charge |
Movable Property
(not being pledge) Book Debts |
|
Particulars of
the charge holder |
Bank of India, Bullion Exchange
Branch, 185 Sheikh Memon Street, Kalbadevi Road, Mumbai – 400002,
Maharashtra, India |
|
Nature or
description of the instrument(s) creating or modifying the charge |
Supplemental
Deeds of Hypothecation dated 01.01.2011 |
|
Date of the
instrument creating or modifying the charge |
01.01.2011 |
|
Amount secured by
the charge |
Rs.90.000
Millions |
|
Brief particulars
of the principal terms and conditions and extent and operation of the charge |
Rate of
Interests: Rate of interest
3 % over base rate presently 12.50% p.a. Terms of
Repayments: On Demand Margin: CC Stock -25% Book Debts - 30% Import LC DP -10% Import LC DA 180
Days - 10% Extent and
operation of the charge: As per Bank of India guidelines from time to time |
|
Short particulars
of the property charged (including location of the property) |
All types of drugs
and pharmaceuticals, chemicals etc. All the present
and future book debts, outstanding money receivables, claims bills which are
now due and owing or which may at any time hereafter during the continuance
of this security become due. |
|
Date of instrument
modifying the charge |
27.01.2010 |
|
Particular of the
present modification |
Charge enhanced
from Rs. 65.000 Millions to Rs. 90.000 Millions |
FIXED ASSETS:
·
Furniture and Fixtures
·
Computer
·
Fax Machines
·
Mobile Phone
·
Tea Mixture Machine
·
Air Conditioner
·
Refrigerator
·
Stabilizers
·
Weighing Scale
·
Vehicles
·
UPS System
·
Locking System
·
Telephone
Instruments
·
Cold Storage
·
Trolley Hydraulic Hand Pallet Truck Cap
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market survey
revealed that the amount of compensation sought by the subject is fair and
reasonable and comparable to compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.85 |
|
|
1 |
Rs.84.42 |
|
Euro |
1 |
Rs.72.39 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
--- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
46 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.